6 The revival of group A streptococcal diseases, with a commentary on staphylococcal toxic shock syndrome

Biomedical Research Reports

Volumn 1, Issue C, 1998, Pages 185-218

  Musser, James M ^a   Krause, Richard M ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957100477     PISSN: 18745326     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1874-5326(07)80030-5     Document Type: Article

References (140)

1. Abbott W.G.H., Skinner M.A., Voss L., Lennon D., Tan P.L.J., Fraser J.D., Simpson I.J., Ameratunga R., and Geursen A. Repertoire of transcribed peripheral blood T-cell-receptor beta chain variable-region genes in acute rheumatic fever. Infect. Immun. 64 (1996) 2842-2845
2. Agerton T., Valway S., Gore B., Pozsik C., Plikaytis B., Woodley C., and Onorato I. Transmission of a highly drug-resistant strain (strain W1) of Mycobacterium tuberculosis. Community outbreak and nosocomial transmission via a contaminated bronchoscope. JAMA 278 (1997) 1073-1077
3. Anthony B.F., Kaplan E.L., Chapman S.S., Quie P.G., and Wannamaker L.W. Epidemic acute nephritis with reappearance of type-49 streptococcus. Lancet 2 (1967) 787-790
4. Bessen D., and Fischetti VA. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes. J. Immunol. 145 (1990) 1251-1256
5. Bessen D., Jones K.F., and Fischetti V.A. Evidence for two distinct classes of streptococcal M protein and their relationship to rheumatic fever. J. Exp. Med. 169 (1989) 269-283
6. Bessen D.E., Sotir C.M., Readdy T.L., and Hollingshead S.K. Genetic correlates of throat and skin isolates of group A streptococci. J. Infect. Dis. 173 (1996) 896-900
7. Bessen D.E., Veasy L.G., Hill H.R., Augustine N.H., and Fischetti VA. Serologic evidence for a class I group A streptococcal infection among rheumatic fever patients. J. Infect. Dis. 172 (1995) 1608-1611
8. Bifani P., Plikaytis B.B., Kapur V., Stockbauer K., Pan X., Lutfey M.L., Moghazeh S.L., Eisner W., Daniel T.M., Kaplan M.H., Crawford J.T., Musser J.M., and Kreiswirth B.N. Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA 275 (1996) 452-457
9. Bisno A.L. Group A streptococcal infections and acute rheumatic fever. N. Engl. J. Med. 325 (1991) 783-793
10. Blomster-Hautamaa D.A., Kreiswirth B.N., Kornblum J.S., Novick R.P., and Schlievert P.M. The nucleotide and partial amino acid sequence of toxic shock syndrome toxin-1. J. Biol. Chem. 261 (1986) 15783-15786
11. Bonventre P.F., Linnemann C., Weckbach L.S., Staneck J.L., Buncher C.R., Vigdorth E., Ritz H., Archer D., and Smith B. Antibody responses to toxic-shock-syndrome (TSS) toxin by patients with TSS and by healthy staphylococcal carriers. J. Infect. Dis. 150 (1984) 662-666
12. Brogan T.V., Nizet V., Waldhausen J.H.T., Rubens C.E., and Clarke W.R. Group A streptococcal necrotizing fasciitis complicating primary varicella: A series of fourteen patients. Pediatr. Infect. Dis. J. 14 (1995) 588-594
13. Broome C.V. Epidemiology of toxic shock syndrome in the United States: Overview. Rev. Infect. Dis. 11 (1989) S14-S21
14. Bucher A., Martin P.R., Høiby E.A., Halstensen A., Odegaard A., Hellum K.B., Westlie L., and Hallan S. Spectrum of disease in bacteraemic patients during a Streptococcus pyogenes serotype M-1 epidemic in Norway in 1988. Eur. J. Clin. Microbiol. Infect. Dis. 11 (1992) 416-426
15. Bullowa J.G.M., and Wishik S.M. Complications of varicella: I. Their occurrence among 2534 patients. Am. J. Dis. Child. 49 (1935) 923-926
16. Carapetis J., Robins-Browne R., Martin D., Shelby-James T., and Hogg G. Increasing severity of invasive group A streptococcal disease in Australia: Clinical and molecular epidemiological features and identification of a new virulent M-nontypeable clone. Clin. Infect. Dis. 21 (1995) 1220-1227
17. Carapetis J.R., Wolff D.R., and Currie B.J. Acute rheumatic fever and rheumatic heart disease in the Top End of Australia's Northern Territory. Med. J. Aust. 164 (1996) 146-149
18. Cartwright K., Logan M., McNulty C., Harrison S., George R., Efstratiou A., McEnvoy M., and Begg N. A cluster of cases of streptococcal necrotizing fasciitis in Gloucestershire. Epidemiol. Infect. 115 (1995) 387-397
19. Centers for Disease Control. Acute rheumatic fever among Army trainees-Fort Leonard Wood, Missouri, 1987-1988. Morbidity and Mortality Weekly Report 37 (1988) 519-522
20. Chelsom J., Halstensen A., Haga T., and Høiby E.A. Necrotising fasciitis due to group A streptococci in western Norway: Incidence and clinical features. Lancet 344 (1994) 1111-1115
21. Cheung A.L., Koomey J.M., Butler C.A., Projan S.J., and Fischetti VA. Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 6462-6466
22. Choi Y., Lafferty J.A., Clements J.R., Todd J.K., Gelfand E.W., Kappler J., Marrack P., and Kotzin B.L. Selective expansion of T cells expressing Vβ2 in toxic shock syndrome. J. Exp. Med. 172 (1990) 981-984
23. Cleary P.P., Kaplan E.L., Handley J.P., Wlazlo A., Kim M.H., Hauser A.R., and Schlievert P.M. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet 339 (1992) 518-521
24. Cockerill III F.R., MacDonald K.L., Thompson R.L., Roberson F., Kohner P.C., Besser-Wiek J., Manahan J.M., Musser J.M., Schlievert P.M., Talbot J., Frankfort B., Steckelberg J.M., Wilson W.R., Osterholm M.T., and the Investigation Team. An outbreak of severe invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA 277 (1997) 38-43
25. Congeni B., Rizzo C., Congeni J., and Sreenivasan V.V. Outbreak of acute rheumatic fever in northeast Ohio. J. Pediatr. 111 (1987) 176-179
26. Courtney H.S., Bronze M.S., Dale J.B., and Hasty D.L. Analysis of the role of M24 protein in group A streptocccal adherence and colonization by use of Ω-interposon mutagenesis. Infect. Immun. 62 (1994) 4868-4873
27. Cowan M.R., Primm P.A., Scott S.M., Abramo T.J., and Wiebe R.A. Serious group A β-hemolytic streptococcal infections complicating varicella. Ann. Emerg. Med. 23 (1993) 818-823
28. Cunningham M.W. Group A streptococci: Molecular mimicry, autoimmunity and infection. In: Hook M., and Switalski L. (Eds). "Microbial Adhesion and Invasion" (1992), Springer-Verlag, New York 149-169
29. Cunningham M.W., Antone S.M., Smart M., Liu R., and Kosanke S. Molecular analysis of human cardiac myosin-cross-reactive B- and T-cell epitopes of the group A streptococcal M5 protein. Infect. Immun. 65 (1997) 3913-3923
30. Dale J.B., and Chiang E.C. Intranasal immunization with recombinant group A streptococcal M protein fragment fused to the B subunit of Escherichia coli labile toxin protects mice against systemic challenge infections. J. Infect. Dis. 171 (1995) 1038-1041
31. Dale J.B., Washburn R.G., Marques M.B., and Wessels M.R. Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci. Infect. Immun. 64 (1996) 1495-1501
32. Davies H.D., McGeer A., Schwartz B., Green K., Cann D., Simor A.E., Low D.E., and The Ontario Group A Streptococcal Study Group. Invasive group A streptococcal infections in Ontario, Canada. N. Engl. J. Med. 335 (1996) 547-554
33. Dean M., Carrington M., Winkler C., Huttley G.A., Smith M.W., Allikmets R., Goedert J.J., Buchbinder S.P., Vittinghoff E., Gomperts E., Donfield S., Vlahov D., Kaslow R., Saah A., Rinaldo C., Detels R., Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study, and O'Brien S.J. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKRS structural gene. Science 273 (1996) 1856-1862
34. de Azavedo J.C., Foster T.J., Hartigan P.J., Arbuthnott J.P., O'Reilly M., Kreiswirth B.N., and Novick R.P. Expression of the cloned toxic shock syndrome toxin 1 gene (tst) in vivo with a rabbit uterine model. Infect. Immun. 50 (1985) 304-309
35. de Malmanche S.A., and Martin D.R. Protective immunity to the group A Streptococcus may be only strain specific. Med. Microbial. Immunol. 183 (1994) 299-306
36. Demers B., Simor A.E., Vellend H., Schlievert P.M., Bryne S., Jamieson F., Walmsley S., and Low D.E. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin. Infect. Dis. 16 (1993) 792-800
37. Denny F.W., Wannamaker L.W., Brink W.R., Rammelkamp Jr. C.H., and Custer E.A. Prevention of rheumatic fever. Treatment of the preceding streptococcic infection. JAMA 143 (1950) 151-153
38. Deresiewicz R.L., Woo J.H., Chan M., Finberg R.W., and Kasper D.L. Mutations affecting the activity of toxic shock syndrome toxin-1. Biochemistry 33 (1994) 12844-12851
39. DiPersio J.R., File Jr. T.M., Stevens D.L., Gardner W.G., Petropoulos G., and Dinsa K. Spread of serious disease-producing M3 clones of group A streptococcus among family members and health care workers. Clin. Infect. Dis. 22 (1996) 490-495
40. Doctor A., Harper M.B., and Fleisher G.R. Group A β-hemolytic streptococcal bacteremia: Historical overview, changing incidence, and recent association with varicella. Pediatrics 96 (1995) 428-433
41. Fattom A.F., and Naso R.B. Vaccines for Staphylococcus aureus infections. In: Levine M.M., Woodrow G.C., Kaper J.B., and Cobon G.S. (Eds). "New Generation Vaccines" (1997), Marcel Dekker, Inc., New York 979-988
42. Fischetti V.A. Streptococcal M protein: Molecular design and biological behavior. Clin. Microbiol. Rev. 2 (1989) 285-314
43. Fischetti V.A., Medaglini D., and Pozzi G. Gram-positive commensal bacteria for mucosal vaccine delivery. Curr. Opin. Biotech. 7 (1996) 659-666
44. Gaworzewska E., and Colman G. Changes in the pattern of infection caused by Streptococcus pyogenes. Epidemiol. Infect. 100 (1988) 257-269
45. Givner L.B., Abramson J.S., and Wasilauskas B. Apparent increase in the incidence of invasive group A beta-hemolytic streptococcal disease in children. J. Pediatr. 118 (1991) 341-346
46. Go M.F., Kapur V., Graham D.Y., and Musser J.M. Population genetic analysis of Helicobacter pylori by multilocus enzyme electrophoresis: Extensive allelic diversity and recombinational population structure. J. Bacteriol. 178 (1996) 3934-3938
47. Gray G.C., Escamilla J., Hyams K.C., Struewing J.P., Kaplan E.L., and Tupponce A.K. Hyperendemic Streptococcus pyogenes infection despite prophylaxis with penicillin G benzathine. N. Engl. J. Med. 325 (1991) 92-97
48. Griffiths S.P., and Gersony W.M. Acute rheumatic fever in New York City (1969 to 1988): A comparative study of two decades. J. Pediatr. 116 (1990) 882-887
49. Hanski E., and Caparon M. Protein F, a fibronectin-binding protein, is an adhesin of the group A streptococcus Streptococcus pyogenes. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 6172-6176
50. Harbaugh M.P., Podbielski A., Hugl S., and Cleary P.P. Nucleotide substitutions and small-scale insertion produce size and antigenic variation in group A streptococcal M1 protein. Mol. Microbiol. 8 (1993) 981-991
51. Hasty D.L., Ofek I., Courtney H.S., and Doyle R.J. Multiple adhesins of streptococci. Infect. Immun. 60 (1992) 2147-2152
52. Hoge C.W., Schwartz B., Talkington D.F., Breiman R.F., MacNeill E.M., and Englender S.J. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA 269 (1993) 384-389
53. Holm S.E., Norrby A., Bergholm A.-M., and Norgren M. Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J. Infect. Dis. 166 (1992) 31-37
54. Hosier D.M., Craenen J.M., Teske D.W., and Wheller J.J. Resurgence of acute rheumatic fever. Amer. J. Dis. Child. 141 (1987) 730-733
55. Inagaki Y., Konda T., Murayama S., Yamai S., Matsushima A., Gyobu Y., Tanaka D., Tamaru A., Katsukawa C., Katayama A., Tomita M., Fuchi Y., Hoashi K., Watanabe H., and The Working Group for Group A Streptococci in Japan. Serotyping of Streptococcus pyogenes isolated from common and severe invasive infections in Japan, 1990-5: implication of the T3 serotype strain-expansion in TSLS. Epidemiol. Infect. 119 (1997) 41-48
56. Jevon G.P., Dunne Jr. W.M., Hawkins H.K., Armstrong D.L., and Musser J.M. Fatal group A streptococcal meningitis and toxic shock-like syndrome: Case report. Clin. Infect. Dis. 18 (1994) 91-93
57. Ji G., Beavis R., and Novick R.P. Bacterial interference caused by autoinducing peptide variants. Science 276 (1997) 2027-2030
58. Ji Y., McLandsborough L., Kondagunta A., and Cleary P.P. C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect. Immun. 64 (1996) 503-510
59. Jouanguy E., Altare F., Lamhamedi S.P., Revy J.-F., Emile M., Newport M., Levin S., Blanche E., Seboun A., Fischer J.-L., and Casanova. Interferon-γ-receptor deficiency in an infant with fatal Bacille Calmette-Guerin infection. N. Engl. J. Med. 335 (1996) 1956-1961
60. Kapur V., Nelson K., Schlievert P.M., Selander R.K., and Musser J.M. Molecular population genetic evidence of horizontal spread of two alleles of the pyrogenic exotoxin C gene (speC) among pathogenic clones of Streptococcus pyogenes. Infect. Immun. 60 (1992) 3513-3517
61. Kapur V., Maffei J.T., Greer R.S., Li L.-L., Adams G.J., and Musser J.M. Vaccination with streptococcal extracellular cysteine protease (interleukin-1β convertase) protects mice against challenge with heterologous group A streptococci. Microb. Patbog. 16 (1994) 443-450
62. Kapur V., Kanjilal S., Hamrick M.R., Li L.-L., Whittam T.S., Sawyer S.A., and Musser J.M. Molecular population genetic analysis of the streptokinase gene of Streptococcus pyogenes: Mosaic alleles generated by recombination. Mol. Microbiol. 16 (1995) 509-519
63. Katz A.R., and Morens D.M. Severe streptococcal infections in historical perspective. Clin. Infect. Dis. 14 (1992) 298-307
64. Kaul R., McGeer A., Low D.E., Green K., Schwartz B., Ontario Group A Streptococcal Study, and Simor A.E. Population-based surveillance for group A streptococcal necrotizing fasciitis: Clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Am. J. Med. 103 (1997) 18-24
65. Kawaoka Y., and Webster R.G. Molecular mechanism of acquisition of virulence in influenza virus in nature. Microb. Patbog. 5 (1988) 311-318
66. Kehoe M.A., Kapur V., Whatmore A., and Musser J.M. Horizontal gene transfer among group A streptococci: Implications for pathogenesis and epidemiology. Trends Microbiol. 4 (1996) 436-443
67. Kiska D.L., Thiede B., Caracciolo J., Jordan M., Johnson D., Kaplan E.L., Gruninger R.P., Lohr J.A., Gilligan P.H., and Denny Jr. F.W. Invasive group A streptococcal infections in North Carolina: Epidemiology, clinical features, and genetic and serotype analysis of causative organisms. J. Infect. Dis. 176 (1997) 992-1000
68. Kline J.B., and Collins C.M. Analysis of the superantigenic activity of mutant and allelic forms of streptococcal pyrogenic exotoxin A. Infect. Immun. 64 (1996) 861-869
69. Kornblum J., Kreiswirth B., Projan S.J., Ross H., and Novick R.P. Agr: a polycistronic locus regulating exoprotein synthesis in Staphylococcus aureus. In: Novick R.N., and Skurray R.A. (Eds). "Molecular Biology of the Staphylococci" (1990), VCH, New York 373-402
70. Lancefeld R.C. Specific relationship of cell composition to biological activity of hemolytic streptococci. Harvey Lectures (1940-1941) 36 (1941) 251-290
71. LaPenta D., Rubens C., Chi E., and Cleary P.P. Group A streptococci efficiently invade human respiratory epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 12115-12119
72. Lee P.K., Kreiswirth B.N., Deringer J.R., Projan S.J., Eisner W., Smith B.L., Carlson E., Novick R.P., and Schlievert P.M. Nucleotide sequences and biologic properties of toxic shock syndrome toxin 1 from ovine- and bovine-associated Staphylococcus aureus. J. Infect. Dis. 165 (1992) 1056-1063
73. Leggiadro R.J., Birnbaum S.E., Chase N.A., and Myers L.K. A resurgence of acute rheumatic fever in a mid-South children's hospital. S. Med. J. 83 (1990) 1418-1420
74. Lukomski S., Sreevatsan S., Amberg C., Reichardt W., Woischnik M., Podbielski A., and Musser J.M. Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains. J. Clin. Invest. 99 (1997) 2574-2580
75. Lukomski S., Burns Jr. E.H., Wyde P.R., Podbielski A., Rurangirwa J., Moore-Poveda D.K., and Musser J.M. Genetic inactivation of the extracellular cysteine protease (SpeB) expressed by streptococcus pyogenes decreases resistance to phagocytosis and dissemination to organs. Infect. Immun (1998) In press
76. McGeer A., Green K., Cann D., Schwartz B., Kaul R., Fletcher A., Matsumura S., Ontario Group A Streptococcal Study, and Low D.E. Changing epidemiology of invasive group A streptococcal infection-Population based surveillance, Ontario Canada, 1992-5. 35th Intersciences Conference on Antimicrobial Agents and Chemotherapy Annual Meeting, San Francisco, California (1995) (Abstract K135)
77. Madsen S.T. Scarlet fever and erysipelas in Norway during the last hundred years. Infection 1 (1973) 76-81
78. Marciel A.M., Kapur V., and Musser J.M. Molecular population genetic analysis of a Streptococcus pyogenes bacteriophage-encoded hyaluronidase gene: Recombination contributes to allelic diversity. Microb. Pathog. 22 (1997) 209-217
79. Martin D.R., and Single L.A. Molecular epidemiology of group A streptococcus M type 1 infections. J. Infect. Dis. 167 (1993) 1112-1117
80. Martin D.R., and Sriprakash K.S. Epidemiology of group A streptococcal disease in Australia and New Zealand. Rec. Adv. Microbiol. 4 (1996) 1-40
81. Martin P.R., and Hoiby E.A. Streptococcal serogroup A epidemic in Norway 1987-1988. Scand. J. Infect. Dis. 22 (1990) 421-429
82. Moses A.E., Wessels M.R., Zalcman K., Albertí S., Natanson-Yaron S., Menes T., and Hanski E. Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus. Infect. Immun. 65 (1997) 64-71
83. Muotiala A., Seppälä H., Huovinen P., and Vuopio-Varkila J. Molecular comparison of group A streptococci of T1M1 serotype from invasive and noninvasive infections in Finland. J. Infect. Dis. 175 (1997) 392-399
84. Murray D.L., Prasad G.S., Earhart C.A., Leonard B.A.B., Kreiswirth B.N., Novick R.P., Ohlendorf D.H., and Schlievert P.M. Immunological and biochemical properties of mutants of toxic shock syndrome toxin-1. J. Immunol. 152 (1994) 87-95
85. Musser J.M. Molecular population genetic analysis of emerged bacterial pathogens: Selected insights. Emerging Infect. Dis. 2 (1996) 1-17
86. Musser J.M. Streptococcal superantigen, mitogenic factor, and pyrogenic exotoxin B expressed by Streptococcus pyogenes: Structure and function. In: Leung D.Y.M., Huber B.T., and Schlievert P.M. (Eds). "Superantigens: Structure, Biology, and Relevance to Human Disease" (1997) 281-310 Dekker, New York
87. Musser J.M., and Selander R.K. Molecular population genetics of Staphylococcus aureus. In: Novick R.N., and Skurray R.A. (Eds). "Molecular Biology of the Staphylococci" (1990) 59-67 VCH, New York
88. Musser J.M., Schlievert P.M., Chow A.W., Ewan P., Kreiswirth B.N., Rosdahl VT., Naidu A.S., Witte W., and Selander R.K. A single clone of Staphylococcus aureus causes the majority of cases of toxic shock syndrome. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 225-299
89. Musser J.M., Hauser A.R., Kim M.H., Schlievert P.M., Nelson K., and Selander R.K. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: Clonal diversity and pyrogenic exotoxin expression. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 2668-2672
90. Musser J.M., Kapur V., Kanjilal S., Shah U., Musher D.M., Barg N.L., Johnston K.H., Schlievert P.M., Henrichsen J., Gerlach D., Rakita R.M., Tanna A., Cookson B.D., and Huang J.C. Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (scarlet fever toxin). J. Infect. Dis. 167 (1993) 337-346
91. Musser J.M., Kapur V., Peters J.E., Hendrix C.W., Drehner D., Gackstetter G.D., Skalka D.R., Fort P.L., Maffei J.T., Li L.-L., and Melcher G.P. Real-time molecular epidemiologic analysis of an outbreak of Streptococcus pyogenes invasive disease in US Air Force trainees. Arch. Pathol. Lab. Med. 118 (1994) 128-133
92. Musser J.M., Kapur V., Szeto J., Pan X., Swanson D.S., and Martin D.R. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: Recent intercontinental spread of a subclone causing episodes of invasive disease. Infect. Immun. 63 (1995) 994-1003
93. Mylvaganam H., Bjorvatn B., Hofstad T., Hjetland R., Hoiby E.A., and Holm S.E. Small-fragment restriction endonuclease analysis in epidemiological mapping of group A streptococci. J. Med. Microbiol. 40 (1994) 256-260
94. Nakashima K., Ichiyama S., Iinuma Y., Hasegawa Y., Ohta M., Ooe K., Shimizu Y., Igarashi H., Murai T., and Shimokata K. A clinical and bacteriologic investigation of invasive streptococcal infections in Japan on the basis of serotypes, toxin production, and genomic DNA fingerprints. Clin. Infect. Dis. 25 (1997) 260-266
95. Nelson K., Schlievert P.M., Selander R.K., and Musser J.M. Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenes. J. Exp. Med. 174 (1991) 1271-1274
96. Norgren M., Norrby A., and Holm S.E. Genetic diversity in T1 M1 group A streptococci in relation to clinical outcome of infection. J. Infect. Dis. 166 (1992) 1014-1020
97. Norrby-Teglund A., Pauksens K., Holm S.E., and Norgren M. Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestation of disease. J. Infect. Dis. 170 (1994) 585-591
98. Norrby-Teglund A., Kaul R., Low D.E., McGeer A., Newton D.W., Andersson J., Andersson U., and Kotb M. Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production. J. Immunol. 156 (1996) 3057-3064
99. Orskov F., Orskov I., Evans D.J., Sack R.B., and Wadstrom T. Special Escherichia coli serotypes among enterotoxigenic strains from diarrhoea in adults and children. Med. Microbiol. Immunol. 162 (1976) 73-80
100. Perez-Casal J.F., Dillon H.F., Husmann L.K., Graham B., and Scott J.R. Virulence of two Streptococcus pyogenes strains (types M1 and M3) associated with toxic-shock-like syndrome depends on an intact mry-like gene. Infect. Immun. 61 (1993) 5426-5430
101. Perez-Casal J., Price J.A., Maguin E., and Scott J.R. An M protein with a single C repeat prevents phagocytosis of Streptococcus pyogenes: Use of a temperature-sensitive shuttle vector to deliver homologous sequences to the chromosome of Spyogenes. Mol. Microbiol. 8 (1993) 809-819
102. Pichichero M.E. The rising incidence of penicillin treatment failures in group A streptococcal tonsillopharyngitis: An emerging role for the cephalosporins? Pediatr. Infect. Dis. J. 10 (1991) S50-S55
103. Podbielski A., Flosdorff A., and Weber-Heynemann J. The group A streptococcal virR49 gene controls expression of four structural vir regulon genes. Infect. Immun. 63 (1995) 9-20
104. Podbielski A., Schnitzler N., Beyhs P., and Boyle M.D.P. M-related protein (Mrp) contributes to group A streptococcal resistance to phagocytosis by human granulocytes. Mol. Microbiol. 19 (1996) 429-441
105. Prasad G.S., Earhart C.A., Murray D.L., Novick R.P., Schlievert P.M., and Ohlendorf D.H. Structure of toxic shock syndrome toxin 1. Biochemistry 32 (1993) 13761-13766
106. Quinn R.W. Streptococcal infections. In: Evans A.S., and Feldman H.A. (Eds). "Bacterial Infections of Humans: Epidemiology and Control" (1982), Plenum Medical, New York 525-552
107. Quinn R.W. Comprehensive review of morbidity and mortality trends for rheumatic fever, streptococcal disease, and scarlet fever: The decline of rheumatic fever. Rev. Infect. Dis. 11 (1989) 928-953
108. Reda K.B., Kapur V., Goela D., Lamphear J.G., Musser J.M., and Rich R.R. Phylogenetic distribution of streptococcal superantigen SSA allelic variants provides evidence for horizontal transfer of ssa within Streptococcus pyogenes. Infect. Immun. 64 (1996) 1161-1165
109. Schrager H.M., Rheinwald J.G., and Wessels M.R. Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection. J. Clin. Invest. 98 (1996) 1954-1958
110. Schwartz B., Facklam R.R., and Breiman R.F. Changing epidemiology of group A streptococcal infection in the USA. Lancet 336 (1990) 1167-1171
111. Seppälä H., Nissinen A., Järvinen H., Huovinen S., Henriksson T., Herva E., Holm S.E., Jahkola M., Katila M.-L., Klaukka T., Kontiainen S., Liimatainen O., Oinonen S., Passi-Metsomaa L., and Huovinen P. Resistance to erythromycin in group A streptococci. N. Engl. J. Med. 326 (1992) 292-297
112. Seppälä H., Vuopio-Varkila J., Osterblad M., Jahkola M., Rummukainen M., Holm S.E., and Huovinen P. Evaluation of methods for epidemiologic typing of group A streptococci. J. Infect. Dis. 169 (1994) 519-525
113. Seppälä H., He Q., Österblad M., and Huovinen P. Typing of group A streptococci by random amplified polymorphic DNA analysis. J. Clin. Microbiol. 32 (1994) 1945-1948
114. Sloane R., de Azavedo J.C., Arbuthnott J.P., Hartigan P.J., Kreiswirth B., Novick R., and Foster T.J. A toxic shock syndrome toxin mutant of Staphylococcus aureus isolated by allelic replacement lacks virulence in a rabbit uterine model. FEMS Microbiol. Lett. 78 (1991) 239-244
115. Stegmayr B., Björck S., Holm S., Nisell J., Rydvall A., and Settergren B. Septic shock induced by group A streptococcal infection: Clinical and therapeutic aspects. Scand. J. Infect. Dis. 24 (1992) 589-597
116. Stetson C.A., Rammelkamp Jr. C.H., Krause R.M., Kohen R.J., and Perry W.D. Epidemic acute nephritis: Studies on etiology, natural history and prevention. Medicine 34 (1955) 431-450
117. Stevens D.L. Streptococcal toxic-shock syndrome: Spectrum of disease, pathogenesis, and new concepts in treatment. Emerging Infect. Dis. 1 (1995) 69-78
118. Stevens D.L., Tanner M.H., Winship J., Swarts R., Ries K.M., Schlievert P.M., and Kaplan E. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N. Engl. J. Med. 321 (1989) 1-7
119. Stockbauer K.E., Grigsby D., Pan X., Perea Mejia L.M., Cravioto A., and Musser J.M. Hypervariability generated by natural selection in an extracellular complement inhibiting protein made by serotype M1 strains of group A Streptococcus. Proc. Natl. Acad. Sci. USA. (1997) In press
120. Stollerman G.H. Rheumatic fever. Lancet 349 (1997) 935-942
121. Strömberg A., Romanus V., and Burman L.G. Outbreak of group A streptococcal bacteremia in Sweden: An epidemiologic and clinical study. J. Infect. Dis. 164 (1991) 595-598
122. Taranta A., Torosdag S., Metrakos J.D., Jegier W., and Uchida I. Rheumatic fever in monozygotic and dizygotic twins. Circulation 20 (1959) 778
123. The Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA 269 (1993) 390-391
124. Thibodeau J., and Sekaly R.-P. "Bacterial Superantigens: Structure, Function and Therapeutic Potential." (1995), R. G. Landes, Austin, Texas
125. Todd J.K. Toxic shock syndrome. Clin. Microbiol. Rev. 1 (1988) 432-446
126. Todd J., Fishaut M., Kapral F., and Welch T. Toxic shock syndrome associated with phage-group-I staphylococci. Lancet 2 (1978) 1116-1118
127. Unny S.K., and Middlebrooks B.L. Streptococcal rheumatic carditis. Microbiol. Rev. 47 (1983) 97-120
128. Upton M., Carter P.E., Morgan M., Edwards G.F.S., and Pennington T.H. Clonal structure of invasive Streptococcus pyogenes in Northern Scotland. Epidemiol. Infect. 115 (1995) 231-241
129. Upton M., Carter P.E., Orange G., and Pennington T.H. Genetic heterogeneity of M type 3 group A streptococci causing severe infections in Tayside, Scotland. J. Clin. Microbiol. 34 (1996) 196-198
130. Veasy L.G., Wiedmeier S.E., Orsmond G.S., Ruttenberg H.D., Boucek M.M., Roth S.J., Tait V.F., Thompson J.A., Daly J.A., Kaplan E.L., and Hill H.R. Resurgence of acute rheumatic fever in the intermountain area of the United States. N. Engl. J. Med. 316 (1987) 421-427
131. Vugia D.J., Peterson C.L., Meyers H.B., Kim K.S., Arrieta A., Schlievert P.M., Kaplan E.L., Werner S.B., and Mascola L. Invasive group A streptococcal infections in children with varicella in southern California. Pedaatr. Infect. Dis. J. 15 (1996) 146-150
132. Wald E.R., Dashefsky B., Feidt C., Chiponis D., and Byers C. Acute rheumatic fever in western Pennsylvania and the tristate area. Pediatrics 80 (1987) 371-374
133. Wessels M.R., and Bronze M.S. Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 12238-12242
134. Wessels M.R., Moses A.E., Goldberg J.B., and DiCesare T.J. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 8317-8321
135. Wessels M.R., Goldberg J.B., Moses A.E., and DiCesare T.J. Effects on virulence of mutations in a locus essential for hyaluronic acid capsule expression in group A streptococci. Infect. Immun. 62 (1994) 433-441
136. Westlake R.M., Graham T.P., and Edwards K.M. An outbreak of acute rheumatic fever in Tennessee. Pediatr. Infect. Dis. J. 9 (1990) 97-100
137. Whatmore A.M., Kapur V., Sullivan D.J., Musser J.M., and Kehoe M.A. Non-congruent relationships between variation in emm gene sequences and the population genetic structure of group A streptococci. Mol. Microbiol. 14 (1994) 619-631
138. Whatmore A.M., Kapur V., Musser J.M., and Kehoe M.A. Molecular population genetic analysis of the enn subdivision of group A streptococcal emm-like genes: Horizontal gene transfer and restricted variation among enn genes. Mol. Microbiol. 15 (1995) 1039-1048
139. Wheeler M.C., Roe M.H., Kaplan E.L., Schlievert P.M., and Todd J.K. Outbreak of group A streptococcus septicemia in children. JAMA 266 (1991) 533-537
140. Zabriskie J.B. Rheumatic fever: The interplay between host, genetics, and microbe. Circulation 71 (1985) 1077-1086